NFKB1 and obesity disorder: TNF-α is one of the key mediators of obesity-associated inflammation and can inhibit insulin signaling by activating the JNK/NF-κB pathways, impairing insulin receptor phosphorylation, and contributing to hepatic lipotoxicity (28).